The document describes the high-throughput antibody production services of Creative Biolabs. They have adopted mature technologies and are vigilant about emerging concepts to perfect their superior antibody screening and expression service. Their service can perform high-throughput antibody expression in various hosts with sufficient yields. Many of the antibodies produced have been successfully applied in research and drug development. Their gene synthesis and expression technologies allow them to screen and produce targeted antibodies with customized characteristics in optimized cell lines. They have created an efficient system for high-throughput gene synthesis and cloning using advanced technologies. Their high-throughput capacity covers 96-well, 384-well, and emerging higher throughput formats based on researcher needs. They guarantee screening and production within 4 weeks starting from sequences.